109 results
424B5
GOVX
Geovax Labs Inc
21 May 24
Prospectus supplement for primary offering
12:32pm
exceed policy limits, divert management’s attention, and adversely affect our reputation and demand for our products.
Reimbursement decisions by third
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
liability claims, regardless of their merits, could exceed policy limits, divert management’s attention, and adversely affect our reputation
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
, regardless of their merits, could exceed policy limits, divert management’s attention, and adversely affect our reputation and demand for our products
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
reputation and demand for our products.
Reimbursement decisions by third-party payors may have an adverse effect on pricing and market acceptance
POS AM
in7zcd5575 vu
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
424B3
x9w8d1e7
12 Jan 24
Prospectus supplement
4:00pm
S-8
EX-99.2
r4y0ibxvu79ej gp
22 Aug 23
Registration of securities for employees
4:06pm
S-8
EX-99.1
r32q3v66xawgupn5jo
22 Aug 23
Registration of securities for employees
4:06pm
424B5
scrsw62z5gp44
18 Jul 23
Prospectus supplement for primary offering
4:13pm
8-K
EX-10.1
l2db4pm0n5
8 Dec 22
GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors
3:53pm
424B3
q3xbs61 b5gj
27 Jun 22
Prospectus supplement
9:13am
424B5
nii98
27 May 22
Prospectus supplement for primary offering
8:49am
POS AM
hj4mab593h 0fgsf5
9 Mar 22
Prospectus update (post-effective amendment)
8:42pm